Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

April 2010
1. FWU CW , Chien YC, Nelson KE, Kirk GD, et al
   Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from taiwan.
   J Infect Dis. 2010;201:1016-23.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2010
2. TANG X , Wagoner J, Negash A, Austin M, et al
   Functional characterization of core genes from patients with acute hepatitis C virus infection.
   J Infect Dis. 2010;201:912-22.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. HSU HY , Chang MH, Ni YH, Chiang CL, et al
   No Increase in Prevalence of Hepatitis B Surface Antigen Mutant in a Population of Children and Adolescents Who Were Fully Covered by Universal Infant Immunization.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. KOVACS A , Karim R, Mack WJ, Xu J, et al
   Activation of CD8 T Cells Predicts Progression of HIV Infection in Women Coinfected with Hepatitis C Virus.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. SHERMAN KE , Rouster SD, Stanford S, Blackard JT, et al
   Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV-Coinfected Subjects Treated with Interferon-Based Regimens.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. HUANG CF , Yang JF, Dai CY, Huang JF, et al
   Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. HUIK K , Sadam M, Karki T, Avi R, et al
   CCL3L1 Copy Number Is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HAGAN H , Pouget ER, Williams IT, Garfein RL, et al
   Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
9. MENZO S , Vincenti D, Solmone M, Prosperi M, et al
   Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
   J Infect Dis. 2009;200:1798-9.
   PubMed     Text format     Related articles   
   
   
   November 2009
10. ANTONUCCI G , Angeletti C, Vairo F, Longo MA, et al
    Age and prediction of sustained virological response to hepatitis C virus (HCV) infection treatment based on 28-day decrease in HCV RNA levels.
    J Infect Dis. 2009;200:1484-5.
    PubMed     Text format     Related articles   
    
    
    October 2009
11. JHAVERI R , Qiang G, Diehl AM
    Domain 3 of Hepatitis C Virus Core Protein Is Sufficient for Intracellular Lipid Accumulation.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. ZEREMSKI M , Dimova R, Brown Q, Jacobson IM, et al
    Peripheral CXCR3-Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PAGE K , Hahn JA, Evans J, Shiboski S, et al
    Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.
    J Infect Dis. 2009;200:1216-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
14. MCMAHON BJ , Dentinger CM, Bruden D, Zanis C, et al
    Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. SCHULTE D , Vogel M, Langhans B, Kramer B, et al
    The HLA-E(R)/HLA-E(R) Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E-Restricted Recognition of an HCV-Derived Peptide by Interferon-gamma-Secreting Human CD8(+) T Cells.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. COQUILLARD G , Patterson BK
    Determination of Hepatitis C Virus-Infected, Monocyte Lineage Reservoirs in Individuals With or Without HIV Coinfection.
    J Infect Dis. 2009;200:947-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. WALZ A , Wirth S, Hucke J, Gerner P, et al
    Vertical Transmission of Hepatitis B Virus (HBV) from Mothers Negative for HBV Surface Antigen and Positive for Antibody to HBV Core Antigen.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
18. AKHAVAN S , Schnuriger A, Lebray P, Benhamou Y, et al
    Natural Variability of NS3 Protease in Patients Infected with Genotype 4 Hepatitis C Virus (HCV): Implications for Antiviral Treatment Using Specifically Targeted Antiviral Therapy for HCV.
    J Infect Dis. 2009;200:524-527.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. ALLISON RD , Katsounas A, Koziol DE, Kleiner DE, et al
    Association of Interleukin-15-Induced Peripheral Immune Activation with Hepatic Stellate Cell Activation in Persons Coinfected with Hepatitis C Virus and HIV.
    J Infect Dis. 2009;200:619-623.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. JAIN MK , Yuan HJ, Adams-Huet B, Reeck A, et al
    Pegylated Interferon and Ribavirin Promote Early Evolution of Nonstructural 5A Protein in Individuals with Hepatitis C Who Demonstrate a Response to Treatment.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. MCGOVERN BH , Nagami EH, Birch CE, Bowen MJ, et al
    Rate of Sustained Virologic Response in Relation to Baseline Hepatitis C Virus (HCV) RNA Level and Rapid Virologic Clearance in Persons with Acute HCV Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. ABZUG MJ , Warshaw M, Rosenblatt HM, Levin MJ, et al
    Immunogenicity and Immunologic Memory after Hepatitis B Virus Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
23. BHANICH SUPAPOL W , Remis RS, Raboud J, Millson M, et al
    Mother-to-Child Transmission of GB Virus C in a Cohort of Women Coinfected with GB Virus C and HIV in Bangkok, Thailand.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. NOGUCHI C , Imamura M, Tsuge M, Hiraga N, et al
    G-to-A Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection.
    J Infect Dis. 2009;199:1599-1607.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
25. KUNIHOLM MH , Purcell RH, McQuillan GM, Engle RE, et al
    Epidemiology of Hepatitis E Virus in the United States: Results from the Third National Health and Nutrition Examination Survey, 1988-1994.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. POOVORAWAN Y , Chongsrisawat V, Theamboonlers A, Srinivasa K, et al
    Long-Term Benefit of Hepatitis B Vaccination among Children in Thailand with Transient Hepatitis B Virus Infection Who Were Born to Hepatitis B Surface Antigen-Positive Mothers.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. LIANG X , Bi S, Yang W, Wang L, et al
    Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992-2005 in China.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. PASCUAL PAREJA JF , Montes ML, Gonzalez-Garcia J, Arribas JR, et al
    Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in European HIV-Infected Patients with Anti-HCV Antibodies.
    J Infect Dis. 2009;199:1556-7.
    PubMed     Text format     Related articles   
    
    
    April 2009
29. KIESSLICH D , Crispim MA, Santos C, Ferreira FD, et al
    Influence of Hepatitis B Virus (HBV) Genotype on the Clinical Course of Disease in Patients Coinfected with HBV and Hepatitis Delta Virus.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
30. MARGERIDON-THERMET S , Shulman NS, Ahmed A, Shahriar R, et al
    Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. VIVEKANANDAN P , Thomas D, Torbenson M
    Methylation Regulates Hepatitis B Viral Protein Expression.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. BARNES E , Gelderblom HC, Humphreys I, Semmo N, et al
    Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection.
    J Infect Dis. 2009;199:819-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. TAI AW , Chung RT
    Racial Differences in Response to Interferon-Based Antiviral Therapy for Hepatitis C Virus Infection: A Hardwiring Issue?
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
34. HOOFNAGLE JH , Wahed AS, Brown Jr RS, Howell CD, et al
    Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. KIM AY , Timm J, Nolan BE, Reyor LL, et al
    Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individual.
    J Infect Dis. 2009;199:737-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. KONDO Y , Machida K, Liu HM, Ueno Y, et al
    Hepatitis C Virus Infection of T Cells Inhibits Proliferation and Enhances Fas-Mediated Apoptosis by Down-Regulating the Expression of CD44 Splicing Variant 6.
    J Infect Dis. 2009;199:726-736.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. LIU CJ , Jeng YM, Chen CL, Cheng HR, et al
    Hepatitis B virus Basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
    J Infect Dis. 2009;199:742-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
38. CRANE M , Oliver B, Matthews G, Avihingsanon A, et al
    Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals after the Initiation of HBV-Active Antiretroviral Therapy.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. BARNES E , Gelderblom HC, Humphreys I, Semmo N, et al
    Cellular Immune Responses during High-Dose Interferon-alpha Induction Therapy for Hepatitis C Virus Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
40. JENSEN TB , Gottwein JM, Scheel TK, Hoegh AM, et al
    Highly Efficient JFH1-Based Cell-Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing-Antibody Treatment to Control Infection.
    J Infect Dis. 2008;198:1756-1765.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
41. WICHMANN O , Schimanski S, Koch J, Kohler M, et al
    Phylogenetic and Case-Control Study on Hepatitis E Virus Infection in Germany.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. KUNIHOLM MH , Nelson KE
    Of Organ Meats and Hepatitis E Virus: One Part of a Larger Puzzle Is Solved.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles   
    
    
    
43. PANDEY JP , Namboodiri AM, Luo Y, Wu Y, et al
    Genetic Markers of IgG Influence the Outcome of Infection with Hepatitis C Virus.
    J Infect Dis. 2008;198:1334-1336.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
44. HAMMITT LL , Bulkow L, Hennessy TW, Zanis C, et al
    Persistence of Antibody to Hepatitis A Virus 10 Years after Vaccination among Children and Adults.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. THURAIRAJAH PH , Hegazy D, Chokshi S, Shaw S, et al
    Hepatitis C Virus (HCV)-Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. MCCARTNEY EM , Semendric L, Helbig KJ, Hinze S, et al
    Alcohol Metabolism Increases the Replication of Hepatitis C Virus and Attenuates the Antiviral Action of Interferon.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. CHEN M , Zhang D, Zhen W, Shi Q, et al
    Characteristics of Circulating T Cell Receptor gammadelta T Cells from Individuals Chronically Infected with Hepatitis B Virus (HBV): An Association between V(delta)2 Subtype and Chronic HBV Infection.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. YEH CT , Hsu CW, Chang ML, Tsao ML, et al
    Impact of the Novel Hepatotropic Viruslike Agent NV-F during Chronic Hepatitis C Virus Infection.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CHEN CH , Changchien CS, Lee CM, Hung CH, et al
    Combined Mutations in Pre-S/Surface and Core Promoter/Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma: A Case-Control Study.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. KURBANOV F , Tanaka Y, Chub E, Maruyama I, et al
    Molecular Epidemiology and Interferon Susceptibility of the Natural Recombinant Hepatitis C Virus Strain RF1_2k/1b.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. DOWD KA , Hershow RC, Yawetz S, Larussa P, et al
    Maternal Neutralizing Antibody and Transmission of Hepatitis C Virus to Infants.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. SCHRAMM F , Soulier E, Royer C, Weitten T, et al
    Frequent Compartmentalization of Hepatitis C Virus with Leukocyte-Related Amino Acids in the Setting of Liver Transplantation.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. HENKE-GENDO C , Amini-Bavil-Olyaee S, Challapalli D, Trautwein C, et al
    Symptomatic Hepatitis B Virus (HBV) Reactivation despite Reduced Viral Fitness Is Associated with HBV Test and Immune Escape Mutations in an HIV-Coinfected Patient.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. CIESEK S , Steinmann E, Manns MP, Wedemeyer H, et al
    The Suppressive Effect That Myriocin Has on Hepatitis C Virus RNA Replication Is Independent of Inhibition of Serine Palmitoyl Transferase.
    J Infect Dis. 2008;198:1091-1093.
    PubMed     Text format     Related articles   
    
    
    September 2008
55. AN P , Thio CL, Kirk GD, Donfield S, et al
    Regulatory Polymorphisms in the Interleukin-18 Promoter Are Associated with Hepatitis C Virus Clearance.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. BRUNO R , Sacchi P
    Spontaneous Hepatitis C Virus Clearance in HIV-Infected Patients: New Insights for Improving Management.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles   
    
    
    
57. SORIANO V , Mocroft A, Rockstroh J, Ledergerber B, et al
    Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV-Infected Patients with Anti-HCV Antibodies in Europe.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
58. OHKAWA K , Takehara T, Kato M, Deguchi M, et al
    Supportive Role Played by Precore and PreS2 Genomic Changes in the Establishment of Lamivudine-Resistant Hepatitis B Virus.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
59. WARD SM , Phalora P, Bradshaw D, Leyendeckers H, et al
    Direct Ex Vivo Evaluation of Long-Lived Protective Antiviral Memory B Cell Responses against Hepatitis B Virus.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. FUNG J , Lai CL, Hung I, Young J, et al
    Chronic Hepatitis C Virus Genotype 6 Infection: Response to Pegylated Interferon and Ribavirin.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. BARTELS DJ , Zhou Y, Zhang EZ, Marcial M, et al
    Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3.4A Protease Inhibitors in Treatment-Naive Subjects.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. FANNING LJ
    Practical Consequences of Hepatitis C Virus Quasispecies for Target-Specific Antivirals.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles   
    
    
    June 2008
63. VO TT , Ledergerber B, Keiser O, Hirschel B, et al
    Durability and Outcome of Initial Antiretroviral Treatments Received during 2000-2005 by Patients in the Swiss HIV Cohort Study.
    J Infect Dis. 2008;197:1685-1694.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: